148 related articles for article (PubMed ID: 2166255)
1. D-CPP-ene (SDZ EAA 494), a potent and competitive N-methyl-D-aspartate (NMDA) antagonist: effect on spontaneous activity and NMDA-induced depolarizations in the rat neocortical slice preparation, compared with other CPP derivatives and MK-801.
Lowe DA; Neijt HC; Aebischer B
Neurosci Lett; 1990 Jun; 113(3):315-21. PubMed ID: 2166255
[TBL] [Abstract][Full Text] [Related]
2. Selective N-methyl-D-aspartate (NMDA) antagonists increase gastric motility in the rat.
Shinozaki H; Gotoh Y; Ishida M
Neurosci Lett; 1990 May; 113(1):56-61. PubMed ID: 1973272
[TBL] [Abstract][Full Text] [Related]
3. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use.
Kurumaji A; Nehls DG; Park CK; McCulloch J
Brain Res; 1989 Sep; 496(1-2):268-84. PubMed ID: 2553203
[TBL] [Abstract][Full Text] [Related]
4. NMDA receptor antagonists CPP and MK-801 partially suppress the epileptiform discharges induced by the convulsant drug bicuculline in the rat neocortex.
Hwa GG; Avoli M
Neurosci Lett; 1989 Mar; 98(2):189-93. PubMed ID: 2540464
[TBL] [Abstract][Full Text] [Related]
5. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
[TBL] [Abstract][Full Text] [Related]
6. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of competitive and non-competitive N-methyl-D-aspartate antagonists on glucose use in the limbic system.
Nehls DG; Kurumaji A; Park CK; McCulloch J
Neurosci Lett; 1988 Aug; 91(2):204-10. PubMed ID: 2847086
[TBL] [Abstract][Full Text] [Related]
8. Effects of antagonists on N-methyl-D-aspartate response in acutely isolated nucleus tractus solitarii neurons of the rat.
Nakagawa T; Shirasaki T; Tateishi N; Murase K; Akaike N
Neurosci Lett; 1990 May; 113(2):169-74. PubMed ID: 1974040
[TBL] [Abstract][Full Text] [Related]
9. Effects of the NMDA receptor/channel antagonists CPP and MK801 on hippocampal field potentials and long-term potentiation in anesthetized rats.
Abraham WC; Mason SE
Brain Res; 1988 Oct; 462(1):40-6. PubMed ID: 2846123
[TBL] [Abstract][Full Text] [Related]
10. Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene.
Bullock R; Graham DI; Chen MH; Lowe D; McCulloch J
J Cereb Blood Flow Metab; 1990 Sep; 10(5):668-74. PubMed ID: 2166743
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor.
Nevins ME; Arnolde SM
Brain Res; 1989 Nov; 503(1):1-4. PubMed ID: 2558775
[TBL] [Abstract][Full Text] [Related]
12. Evidence that NMDA receptors contribute to synaptic function in the guinea pig medial vestibular nucleus.
Smith PF; Darlington CL; Hubbard JI
Brain Res; 1990 Apr; 513(1):149-51. PubMed ID: 2161695
[TBL] [Abstract][Full Text] [Related]
13. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
Foster AC; Wong EH
Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
[TBL] [Abstract][Full Text] [Related]
14. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
[TBL] [Abstract][Full Text] [Related]
15. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
[TBL] [Abstract][Full Text] [Related]
16. Homocysteic acid as a putative excitatory amino acid neurotransmitter: I. Postsynaptic characteristics at N-methyl-D-aspartate-type receptors on striatal cholinergic interneurons.
Lehmann J; Tsai C; Wood PL
J Neurochem; 1988 Dec; 51(6):1765-70. PubMed ID: 2846784
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of febrile seizures in epileptic chicks by N-methyl-D-aspartate receptor antagonists.
Pedder SC; Wilcox RI; Tuchek JM; Johnson DD; Crawford RD
Can J Physiol Pharmacol; 1990 Jan; 68(1):84-8. PubMed ID: 2158387
[TBL] [Abstract][Full Text] [Related]
18. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
Marrannes R; Willems R; De Prins E; Wauquier A
Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of dopamine release from cultured rat mesencephalic cells by naturally occurring excitatory amino acids: involvement of both N-methyl-D-aspartate (NMDA) and non-NMDA receptor subtypes.
Mount H; Quirion R; Chaudieu I; Boksa P
J Neurochem; 1990 Jul; 55(1):268-75. PubMed ID: 1972390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
